Global HERG Screening Market | Market Demand & Forecast

According to FutureWise analysis the market for HERG screening in 2025 is US$ 2.12 billion, and is expected to reach US$ 5.76 billion by 2033 at a CAGR of 13.31%. The increasing focus on cardiac safety assessment in drug development is a significant factor driving the adoption of hERG screening technologies. Pharmaceutical and biotech companies are progressively incorporating advanced in vitro and in silico assays to identify potential cardiotoxicity risks early in the development process.

The human Ether-a-go-go-Related Gene (HERG) encodes for the Kv11.1 protein, a vital alpha subunit of a potassium ion channel. These channels play an essential role in regulating the heartbeat by facilitating a repolarizing current during the cardiac action potential. HERG assessments are crucial requirements set by regulatory agencies prior to the submission of Investigational New Drug applications.

Various assays are employed for HERG screening, including manual or automated patch clamp assays, HERG radioligand binding tests, fluorescence polarization analysis, and microelectrode arrays. The automated patch clamp assay evaluates HERG currents at different test compound concentrations, measuring responses both before and after exposure. The method known as dose formulation analysis is used to determine IC50 values, with additional assays performed according to their specific protocols.

The HERG screening process offers numerous benefits, particularly as the HERG channel serves as a target for medications designed to treat class III arrhythmias, such as amiodarone. It also reduces the likelihood of re-entrant arrhythmias due to its significant action potential. Furthermore, HERG screening is utilized in identifying potential treatments for various conditions, including cancer, recurring epileptic seizures, and schizophrenia.

An increase in the number of drug approvals, as noted in the Center for Drug Evaluation and Research's (CDER) annual report—which documented 25 new medications receiving endorsement—supports the HERG screening industry's growth. This upward trend in new drug approvals, alongside the rising prevalence of heart diseases, is driving the demand for HERG screening. However, the high costs associated with HERG screening products may pose challenges to market growth in the future. Nevertheless, untapped market opportunities present a promising avenue for expansion in this sector.

FutureWise Market Research has published a report that provides an insightful analysis of HERG Screening Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=15061&type=requestsample

HERG Screening Market Segmentation:

By Product Type

• Gene KCNH2
• Mutant KCNH2
• Others

By Ion Channel

• Voltage Gated
• Ligand Gated
• Others

By Application

• Antiarrhythmic
• Antipsychotic
• Antibiotic
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in HERG Screening Market:

• Abcam PLC
• ABR-Affinity Bioreagents Inc
• AstraZeneca Plc
• Aureus Sciences
• Aurora Biomed Inc
• AVIVA Biosciences
• B'SyS GmbH
• Caliper
• A PerkinElmer Company
• Cambridge Bioscience Ltd
• Cellular Dynamics
• Eurofins-Cerep SA
• ChanTest Corporation
• Charles River Laboratories Inc
• ChemAxon
• Molecular Devices LLC

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=15061&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the HERG Screening Market By Product Type, By Ion Channel, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/79754-Global-HERG-Screening-Market-Market-Demand-and-Forecast.html